Enrico Morello

1.0k total citations
59 papers, 518 citations indexed

About

Enrico Morello is a scholar working on Hematology, Epidemiology and Genetics. According to data from OpenAlex, Enrico Morello has authored 59 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 18 papers in Epidemiology and 11 papers in Genetics. Recurrent topics in Enrico Morello's work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Enrico Morello is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Enrico Morello collaborates with scholars based in Italy, Germany and France. Enrico Morello's co-authors include Simona Bernardi, Michele Malagola, Domenico Russo, Nicola Polverelli, Alberto Premoli, Marilena Durazzo, Mirko Farina, Giuseppe Rossi, Annarosa Floreani and Alessandro Turra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Hepatology.

In The Last Decade

Enrico Morello

54 papers receiving 512 citations

Peers

Countries citing papers authored by Enrico Morello

Since Specialization

Citations

This map shows the geographic impact of Enrico Morello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrico Morello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrico Morello more than expected).

Fields of papers citing papers by Enrico Morello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrico Morello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrico Morello. The network helps show where Enrico Morello may publish in the future.

Co-authorship network of co-authors of Enrico Morello

This figure shows the co-authorship network connecting the top 25 collaborators of Enrico Morello. A scholar is included among the top collaborators of Enrico Morello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrico Morello. Enrico Morello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 2025 ·Cell Biology International ·(unknown), (unknown), (unknown), Rosalba Monica Ferraro, Elena Laura Mazzoldi, Mirko Farina, (unknown), (unknown), (unknown), Federica Re, (unknown), (unknown), Enrico Morello, Gabriele Magliano, Valeria Cancelli, Silvia Giliani, Michele Malagola, Domenico Russo, Simona Bernardi	4
2	Bowel urgency in ulcerative colitis assessed from patients’ reports: Results of a telemonitoring programme 2025 ·Digestive and Liver Disease ·(unknown), (unknown), (unknown), Benigno Rodríguez, Enrico Morello, (unknown), A. Lavagna, (unknown), Rodolfo Rocca, Marco Daperno	0
3	Gene expression patterns of the LDL receptor and its inhibitor Pcsk9 in the adult zebrafish brain suggest a possible role in neurogenesis 2024 ·European Journal of Neuroscience ·(unknown), Enrico Morello, Sepand Rastegar, (unknown), Olivier Meilhac, Jean‐Loup Bascands, Nicolas Diotel	1
4	Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group 2024 ·Frontiers in Nutrition ·(unknown), Helen Jessop, (unknown), (unknown), Jörg Henes, (unknown), Anna Carmagnola, Enrico Morello, (unknown), (unknown), (unknown), Michelle Kenyon, Tobias Alexander, Ariadna Domènech, Raffaella Greco	0
5	Nutritional Strategies To Improve VRE Control 2024 ·Transplantation and Cellular Therapy ·Enrico Morello, (unknown), (unknown), Liana Signorini, (unknown), (unknown), Simona Bernardi, Michele Malagola, Mirko Farina, (unknown), Gabriele Magliano, Simona Fiorentini, Arnaldo Caruso, Domenico Russo	2
6	High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 2023 ·Frontiers in Oncology ·(unknown), Mirko Farina, Luisa Lorenzi, Nicola Polverelli, (unknown), Enrico Morello, (unknown), Camillo Almici, (unknown), Andrea Bianchetti, (unknown), Federica Re, (unknown), Simona Bernardi, Michele Malagola, Alessandro Re, Domenico Russo	7
7	Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 2023 ·Transplant Immunology ·Enrico Morello, (unknown), Simona Bernardi, Vincenzo Villanacci, (unknown), Mirko Farina, (unknown), (unknown), (unknown), Nicola Polverelli, (unknown), (unknown), Francesco Arena, Chiara Ricci, Michele Malagola, Domenico Russo	7
8	Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 2023 ·Frontiers in Oncology ·Michele Malagola, Nicola Polverelli, (unknown), (unknown), (unknown), Mirko Farina, Enrico Morello, (unknown), (unknown), Simona Bernardi, Federica Re, (unknown), (unknown), Duilio Brugnoni, Arnalda Lanfranchi, Domenico Russo	5
9	Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 2022 ·Frontiers in Oncology ·Michele Malagola, Alessandro Turra, Liana Signorini, Silvia Corbellini, Nicola Polverelli, (unknown), (unknown), Silvia Lorenzotti, (unknown), Mirko Farina, Enrico Morello, (unknown), (unknown), (unknown), Simona Bernardi, Federica Re, Arnaldo Caruso, Francesco Castelli, Domenico Russo	9
10	Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies 2021 ·Vaccines ·(unknown), Silvia Corbellini, Giorgio Piccinelli, Alessandro Turra, Enrico Morello, Michele Malagola, Domenico Russo, Arnaldo Caruso, Maria Antonia De Francesco	1
11	A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 2021 ·Frontiers in Immunology ·Enrico Morello, (unknown), Francesco Arena, (unknown), Simona Bernardi, Michele Malagola, Alessandro Turra, Nicola Polverelli, Domenico Russo	15
12	Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 2020 ·Frontiers in Oncology ·Michele Malagola, Nicola Polverelli, (unknown), (unknown), Simona Bernardi, (unknown), Federica Re, Enrico Morello, Alessandro Turra, Alessandro Isidori, Domenico Russo	3
13	Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients 2020 ·Bone Marrow Transplantation ·Nicola Polverelli, (unknown), Giorgia Battipaglia, Michele Malagola, Simona Bernardi, (unknown), (unknown), (unknown), Mirko Farina, Enrico Morello, Alessandro Turra, Mohamad Mohty, Domenico Russo	19
14	Predictivity of early and late assessment for post-surgical recurrence of Crohn's disease: Data from a single-center retrospective series 2020 ·Digestive and Liver Disease ·(unknown), (unknown), Michela Mineccia, (unknown), Paolo Massucco, (unknown), C. Rigazio, (unknown), Enrico Morello, E. Ercole, A. Lavagna, Rodolfo Rocca, Alessandro Ferrero, Marco Daperno	5
15	Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 2019 ·SHILAP Revista de lepidopterología ·Michele Malagola, Nicola Polverelli, Valeria Cancelli, Enrico Morello, Alessandro Turra, Erika Borlenghi, Federica Cattina, Benedetta Rambaldi, Simona Bernardi, (unknown), (unknown), (unknown), Mirko Farina, Domenico Russo	1
16	P. aeruginosa bloodstream infections among hematological patients: an old or new question? 2012 ·Annals of Hematology ·Chiara Cattaneo, (unknown), Salvatore Casari, G Ravizzola, Maria Luisa Gelmi, Chiara Pagani, Mariella D’Adda, Enrico Morello, Alessandro Re, Erika Borlenghi, N. Manca, Giuseppe Rossi	72
17	Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression? 2009 ·Journal of Gastroenterology ·Marilena Durazzo, Grazia Anna Niro, Alberto Premoli, Enrico Morello, E. Rosa Rizzotto, Roberto Gambino, Simona Bo, Giovanni Musso, Maurizio Cassader, Gianfranco Pagano, Annarosa Floreani	16
18	Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: Results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 2007 ·American Journal of Hematology ·Michele Falda, Alessandro Busca, Ileana Baldi, Nicola Mordini, Benedetto Bruno, Bernardino Allione, Alessandro Rambaldi, Enrico Morello, Franco Narni, Stella Santarone, Franco Locatelli, Andrea Bacigalupo	18
19	Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study 2006 ·Alimentary Pharmacology & Therapeutics ·Annarosa Floreani, Grazia Anna Niro, E. Rosa Rizzotto, Sara Antoniazzi, Francesco Ferrara, I. Carderi, Vincenzo Baldo, Alberto Premoli, Francesca Olivero, Enrico Morello, Marilena Durazzo	73
20	Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations 2005 ·Leukemia Research ·Roberto Cairoli, Alessandro Beghini, Enrico Morello, Giovanni Grillo, Marco Montillo, Lidia Larizza, Enrica Morra	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact